Results 131 to 140 of about 116,219 (214)

Endoscopic Ultrasound-Guided Radiofrequency Ablation for an Adrenocorticotropic Hormone-Secreting Pancreatic Neuroendocrine Tumor on Antiplatelet Therapy. [PDF]

ACG Case Rep J
Langton O, Sudha Valisekka S, Karna R, Trikudanathan G.   +3 more
europepmc   +1 more source

Bioactive Natural Products in Cardiovascular Disease: Focus on Thrombotic Events

Phytotherapy Research, EarlyView.
An overview of the role of natural products (NP) in cardiovascular disease prevention, highlighting key mechanisms of action: including antiplatelet, antithrombotic, anti‐inflammatory, and antioxidant effects. Additionally, it illustrates the integration of diet–drug interactions, nutritional epigenetics, and the role of artificial intelligence in ...
Maria Nektaria Magkoulia, Despoina Pantazi   +1 more
wiley   +1 more source

Efficacy and Safety of Argatroban as an Adjunct to Antiplatelet Therapy in Ischemic Stroke: An Updated Systematic Review and Meta-analysis. [PDF]

Eur J Clin Pharmacol
Fatima ST, Raza A, Javed A, Ijaz S, Noor M, Uzair SD, Malik AR, Mustafa RA, Daim SUR.   +8 more
europepmc   +1 more source

Pharmacokinetic and Pharmacodynamic Interactions Between Anti‐Asthma Drugs and Medicinal Plants: A Comprehensive Review

Phytotherapy Research, EarlyView.
ABSTRACT Asthma affects 260–300 million people worldwide. About 20%–35% of patients use medicinal plants with their asthma medication, often without telling their clinicians. Disclosure rates are low; up to 42% of asthma outpatients use herbal products, with no records in their charts.
Emine Kocyigit, Aylin Bülbül, Betul Kocaadam‐Bozkurt, Osman Bozkurt, Duygu Ağagündüz, Raffaele Capasso   +5 more
wiley   +1 more source

1-month safety results in a randomized controlled trial (COATING) evaluating a surface-modification flow diverter (p64-MW-HPC) under single antiplatelet treatment. [PDF]

J Neurointerv Surg
Pierot L, Eker OF, Henkes H, Psychogios MN, Cohen J, Lamin S, Pedowski P, Gentric JC, Ciceri E, Holtmannspoetter M, Cognard C, Tsogkas I, Khanafer A, Marnat G, Riva R, Cortese J, Soize S, Willems T, Barreau X, Spelle L.   +19 more
europepmc   +1 more source

A Growing Dark Mass in a Patient With a History of Trauma

JEADV Clinical Practice, EarlyView.
Takahiro Hase, Keisuke Imafuku, Teruki Yanagi, Arisa Tanaka, Ayame Kimura, Suguru Kurosawa, Takashi Seo, Hideyuki Ujiie   +7 more
wiley   +1 more source

Multi‐Target Pharmacological Mechanisms of Salvia miltiorrhiza Bunge in Metabolic Syndrome and Cardiovascular Diseases: A Comprehensive Review Based on the Theory of “Same Treatment for Different Diseases”

Phytotherapy Research, EarlyView.
Salvia miltiorrhiza Bunge in metabolic syndrome and cardiovascular diseases: multi‐target actions on shared signaling pathways. ABSTRACT Metabolic syndrome (MetS) represents a clinical disorder characterized by the clustering of conditions including obesity, elevated blood sugar levels, and high lipid levels, which are intricately linked to the onset ...
Zhiyi Jia, Kaiyi Wu, Jiaying Qi, Nana Huang, Yusheng Liu, Xiumei Gao, Rong Sun   +6 more
wiley   +1 more source

Left atrial appendage occlusion versus antithrombotic therapy in nonvalvular AF with ASCVD and prior embolism. [PDF]

iScience
Lu C, Sun S, Liu H, Chen L, Ni Q, Yuan Y, Chen J, Zhang C, Ruan Z, Ding X.   +9 more
europepmc   +1 more source

Potential of Ginkgo biloba Extract to Intervene in Chronic Inflammation‐Related Diseases

Phytotherapy Research, EarlyView.
Chronic inflammation is a pathological mechanism underpinning many diseases. Ginkgo biloba extract (GBE) is well known for its anti‐inflammatory property. GBE and its active constituents have been shown to attenuate pro‐inflammatory cytokine production, suppress nuclear factor kappa B activation, restore redox homeostasis, and modulate disease‐relevant
Yipeng Lin, Inho Cho, Xue Zhu, Ke Wang, Ling Zhu, Wenchang Wong, Michael Murray, Fanfan Zhou   +7 more
wiley   +1 more source

Microfluidics Lab‐on‐a‐Chip Approaches to Decipher Atherosclerosis Pathogenesis

Small, EarlyView.
Figure created with BioRender.com. This review highlights how microfluidic lab‐on‐a‐chip models recreate key features of atherosclerosis in controlled, human‐relevant environments. It summarizes advances in modeling endothelial dysfunction, immune cell recruitment, foam cell formation, vascular remodeling, stenosis, and plaque rupture.
Fahima Akther, Hang Thu Ta
wiley   +1 more source